Dr. Martens plc (FRA:3U2)

Germany flag Germany · Delayed Price · Currency is EUR
0.7300
-0.0200 (-2.67%)
Last updated: Apr 24, 2026, 8:04 AM CET
Market Cap741.78M +35.7%
Revenue (ttm)900.28M -2.6%
Net Income17.55M -48.0%
EPS0.02 -49.2%
Shares Outn/a
PE Ratio42.27
Forward PE14.23
Dividend0.03 (3.93%)
Ex-Dividend DateMar 5, 2026
Volumen/a
Average Volume8
Open0.7300
Previous Close0.7500
Day's Range0.7300 - 0.7300
52-Week Range0.5650 - 1.1100
Betan/a
RSI52.72
Earnings DateMay 29, 2026

About Dr. Martens

Dr. Martens plc engages in the design, development, procurement, marketing, sale, and distribution of footwear. The company sells its footwear under the Dr. Martens brand name in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. Dr. Martens plc was founded in 1945 and is based in London, the United Kingdom. [Read more]

Industry Footwear, Except Rubber
Founded 1945
Employees 3,700
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 3U2

Financial Performance

In fiscal year 2025, Dr. Martens's revenue was 787.60 million, a decrease of -10.20% compared to the previous year's 877.10 million. Earnings were 4.50 million, a decrease of -93.50%.

Financial numbers in GBP Financial Statements

News

Dr. Martens Revenue Drops on Europe, Middle East and Africa Weakness

Chief Executive Ije Nwokorie said the EMEA market continued to be challenging, and that the company had taken a more disciplined promotional stance there.

3 months ago - WSJ

Dr Martens forecasts return to profit growth, shares jump

British bootmaker Dr Martens forecast a return to profit growth in the current financial year on Thursday, backed by its new CEO's plan to put more emphasis on shoes, sandals, and bags, as well as the...

11 months ago - Reuters

Dr. Martens Selects Amperity to Transform Customer Data Strategy

LONDON--(BUSINESS WIRE)-- #AdTech--Amperity, an AI-powered customer data cloud, today announced Dr. Martens, an iconic British brand, has selected its platform to support its global data and marketing...

1 year ago - Business Wire

Dr Martens' shares jump 15% on new CEO's start date despite drop in first half sales

Dr Martens said its new CEO Ije Nwokorie will take over from incumbent Kenny Wilson on Jan. 6 2025, in a shakeup investors hope could boost the struggling boot maker

1 year ago - Market Watch

Dr Martens sees strong US holiday sales, cuts inventory and debt

Dr Martens said on Thursday that the autumn-winter festive season had got off to an encouraging start and investors welcomed a reduction in net debt as the bootmaker tries to turn its performance arou...

1 year ago - Reuters

Dr. Martens shares plunge to record lows on discount bulk sale via Goldman Sachs

Dr. Martens' investors sold 70 million shares in the bootmaker at a price of 57.85 pence per share, in what marks a 10% discount on its closing share price on Thursday

1 year ago - Market Watch

Dr Martens will cut up to £25m in costs to counter weak US sales

British footwear brand does not rule out job losses, while profits fall by 43% to £97m

2 years ago - The Guardian

Dr. Martens Stock Plummets on Downbeat US Outlook

U.K.-listed Dr. Martens PLC issued a downbeat outlook for its U.S. sales on Tuesday, noting that it expects wholesale revenue in the country to be down by double digits for its fiscal 2025 year, and s...

2 years ago - Investopedia

Dr. Martens' profit warning highlights U.S. consumer-confidence challenge

Dr. Martens' profit warning sent shares of the iconic shoe brand tumbling Tuesday and spotlighted consumer-spending challenges on both sides of the Atlantic.

2 years ago - Market Watch

Dr. Martens Shares Tumble as Bootmaker Warns of Tough Year

Dr. Martens shares plummeted after the iconic British footwear and clothing brand said Chief Executive Officer Kenny Wilson plans to step down and warned of a challenging year ahead.

2 years ago - WSJ

Dr. Martens shares lose a third of their value on U.S. warning

Shares of iconic shoe brand Dr. Martens fell as much as 32% on Tuesday with the company's U.S. business going so badly it needs to extend paying for additional storage space as it announced its chief ...

2 years ago - Market Watch

Dr. Martens shares plunge 30% to all-time low, trading briefly halted on weak outlook

Shares of Dr. Martens plunged to a record low in early deals after the shoemaker flagged a challenging 2025 outlook.

2 years ago - CNBC

Bootmaker Dr Martens names new CEO, flags tough year on weak demand

British bootmaker Dr Martens named its chief brand officer Ije Nwokorie as its next CEO on Tuesday, saying Kenny Wilson had decided this year would be his final year as top boss.

2 years ago - Reuters

Exclusive: Marathon Partners pushes Dr. Martens for strategic review, possible sale

Investment firm Marathon Partners Equity Management wants British boot maker Dr. Martens to hire bankers and begin an immediate strategic review that could lead to a sale of the company, according to ...

2 years ago - Reuters

Dr Martens' revenue plummets by a fifth as US sales plunge

Bootmaker says global sales fell by 18%, with cash-strapped consumers refusing to splash out at Christmas

2 years ago - The Guardian

Bootmaker Dr Martens hit by weak December as US sales slide

Britain's Dr Martens said its visibility over wholesale orders "remains weak" as the bootmaker posted a drop in third-quarter revenue on Thursday following several profit warnings and a disappointing ...

2 years ago - Reuters

Dr. Martens stock leads European gains after report of activist investor buying

Dr. Martens shares DOCS, +5.68% were among Europe's top performers on reports of stake building by an activist investor.

2 years ago - Market Watch

Recycled leather from tannery scrap makes fine shoes and car seats. Just ask Dr. Martens and Jaguar.

Tanning hide into leather might already seem like a sound way to use more of the animal in our lives, after meat and other products. Reality is, tanning typically produces its own considerable waste —...

3 years ago - Market Watch

Dr. Martens Starts 2023 On The Wrong Foot After Second Day Of Stock Declines

The iconic British boot maker has struggled with distribution problems and had to issue another profit warning which did not sit well with investors.

3 years ago - Forbes

Dr. Martens Q3 revenue misses board's expectations

By Ian Walker

3 years ago - Market Watch

Bootmaker Dr. Martens warns on margins as demand slows

British bootmaker Dr. Martens on Thursday warned that its annual core profit margin would be lower than last year because of weaker-than-expected demand ahead of the busy Christmas season, increased i...

3 years ago - Reuters

11:11 Systems Announces New Case Study with Dr. Martens

FAIRFIELD, N.J.--(BUSINESS WIRE)-- #PE--11:11 Systems Announces New Case Study with Dr. Martens on modern data retention and protection best practices for its cloud transition

4 years ago - Business Wire